![]() |
ChatBox AI image created by me |
I generally stay out of the fray when it comes to commentary on politicking, so much of which is about as reliable as a snake-oil pitch.
But having caught Pierre Poilievre’s promise of addiction treatment for 50,000 Canadians, paid out of the money that will be saved when safe-supply
programs are cut, I just can’t let that blatantly misleading statement stand
unchallenged.
First, let’s start with safe supply. That’s the term used
for when people are able to swap out their completely unregulated opioid-based street
drugs for a prescription opioid from a health professional. It’s the most
obvious immediate strategy to stop a toxic drug crisis that has killed 50,000+ Canadians
– more than a quarter of them in BC - in the decade since the anesthetic
fentanyl began dominating the street drug market.
That Poilievre actually thinks there’s enough money in the country’s
teeny-weeny safe-supply response to pay for a major expansion of treatment beds
and the cost of putting people into them for three, four or more times through –
totally predictable with a relapsing health condition – well, that’s the first glaring
sign that this promise is pure snake oil.
Here in BC, we have an estimated 100,000-125,000 people with
opioid use disorder. A mere 4,600 of them are on the safe-supply program that
BC launched at the start of the pandemic. That’s four per cent of the people
who could actually benefit from safe supply.
Elsewhere in Canada, 10 other cities launched pilot safer-supply programs during the pandemic, nine of them in Ontario and one in
Fredericton, NB. Federal funding ran out for most of them already.
In the few short years since, the mercurial public mood has shifted
toward a view of safe supply as having “failed,” even though it actually barely
got a start. So good luck grabbing all that big money invested in safe supply
into treatment, Mr. Poilievre.
What really gets me with stuff like this is that a politician's comments are rarely challenged by reporters, leaving the public to assume that there really is some massive government investment in safe supply that can be transferred over to treatment.
I figure that whichever party ends up elected at the end of
this month, we’ll get a few more treatment beds. That’s a good thing, because
we really need them, along with government funding to support people accessing those
beds without having to come up with tens of thousands of dollars multiple times
to buy their way into a largely private system of care.
But any new beds will barely make a dint on the actual
issues that are troubling the public - one of which is an unregulated drug supply
managed in the shadows by international drug cartels that is killing their
children, grandchildren, employees, partners, siblings and neighbours; and the
other being a multi-faceted crisis of poverty, homelessness and mental illness manifesting
ever more ferociously on the streets of our communities.
Substance use is definitely layered into that latter
problem. But the main driver of the tragedy unfolding on our streets is poverty,
mental illness and a housing crisis. Until we deal with those underlying
causes, we’re going to be living with the soul-searing visibility of enormous
suffering no matter how many treatment beds come into play.
Safe supply is an easy scapegoat for politicians, I suspect
because we’ve been convinced over many decades to view the kind of drugs that
end up on our streets as evil. BC’s tiny safe supply program was dealt a very
hard blow recently when Premier David Eby got fussed about the supply being
diverted into the illicit market, and withdrew people’s right to take their
prescription drugs in the privacy of their own home.
Picture how that would go for whatever prescription drugs
you might be taking, if suddenly you had to visit your local pharmacy twice a
day, within their operating hours, to take your heart drugs, for instance, or
use your asthma puffer.
Your job, your family time, your recreation activities – all
of that would have to fit around getting yourself to the pharmacy twice a day,
every day, to swallow your pills or inject your insulin in front of a health
professional. How long would it take any of us to be looking for alternatives
on the black market to spare us such misery?
Yes, diversion happens. An issue with safe supply is that it
decrees what drugs you can swap onto, and fentanyl isn’t one of them. So some
people on safe supply sell whatever drug they’ve been given to get the money
for the fentanyl that they actually want.
You can look at that as a failure, I suppose. But toxic
substances laced with unknown quantities of fentanyl and fentanyl analogs are now
the No. 1 cause of death for British Columbians ages 10 to 59, exacting a massive
impact on our collective productivity that is second only to cancer. What could
possibly be a bigger failure than that?
So now let’s consider treatment as a “cure” for that
failure, as Poilievre wants us to do.
First, the obvious: Many of the people dead in the toxic
drug crisis weren’t in need of treatment. They were just average people using drugs
for fun – not aberrant behaviour in a country where three-quarters of us consume
alcohol regularly. They died because a toxic drug supply doesn’t differentiate
between whether you’re a first-time user or an “addict.”
Then there’s also this tricky truth: Treatment for any
chronic, relapsing condition is a long, hard slog. Whether it’s Type II
diabetes, hypertension, or this thing we call addiction, 40-60 per cent of people will relapse after treatment. They will need many passes through treatment to reach
a state of recovery, and some will never get there. Getting to where we need to
be in terms of quick access to treatment is going to be expensive, just as it
is for any other long-term health care interventions.
People using opioids are particularly vulnerable to dying
during a relapse, as their tolerance falls significantly after a period of
abstinence. Add in that little ongoing problem of a toxic drug supply - any
hope of accessing safe supply during a relapse having evaporated under
Poilievre’s plan - and it’s clear that expanding treatment alone will not get
us out of this crisis.
And one more tricky truth: Treatment for this thing we call
addiction is almost completely owned by the private sector – and increasingly,
by multinational corporations and private-equity firms interested in consolidating
many small community treatment centres into one big entity that will attract
investors. (As is happening with veterinary services, lab services, mental
health services, employment training, etc.)
Treatment for substance use problems is outside of the
Canada Health Act. Private treatment centres are free to set their own rates
and their own methods. If they report on their effectiveness at all, the data
collection stops the moment a person leaves the centre. A person could relapse
within hours of “graduating” and still be counted as a success.
The lack of transparency and absence of meaningful data
collection leaves us with scarce knowledge to prove or disprove the
effectiveness of any treatment approach. Nobody can actually say what’s working,
or what happens once someone leaves a treatment facility in a state of abstinence
and walks out into the big world where all their troubles await.
We simply don’t know how many times people relapse, because
we don’t measure or track. We don’t know how long an individual stays abstinent
after a round of treatment. There are no national standards for treatment. No
followup.
So yes, let’s talk treatment. It’s a pillar of any
health-care approach, as is access to regulated medications. But please don’t
buy the snake oil.